# Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation

> **NCT00575744** · PHASE2 · COMPLETED · sponsor: **University of Arkansas** · enrollment: 699 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** Sentinel Node Biopsy

## Key facts

- **NCT ID:** NCT00575744
- **Lead sponsor:** University of Arkansas
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-12
- **Primary completion:** 2010-10
- **Final completion:** 2011-10
- **Target enrollment:** 699 (ACTUAL)
- **Last updated:** 2016-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575744, "Sentinel Lymph Node Biopsy Using Peritumoral Injection With Blue Dye Confirmation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00575744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*